GIPC3

Chr 19AR

GIPC PDZ domain containing family member 3

Also known as: C19orf64, DFNB15, DFNB72, DFNB95

The protein encoded by this gene belongs to the GIPC family. Studies in mice suggest that this gene is required for postnatal maturation of the hair bundle and long-term survival of hair cells and spiral ganglion in the ear. Mutations in this gene are associated with autosomal recessive deafness. [provided by RefSeq, Dec 2011]

OMIMResearchGenerating clinical summary…
MultiplemechanismARLOEUF 0.931 OMIM phenotype
Clinical SummaryGIPC3
🧬
Gene-Disease Validity (ClinGen)
nonsyndromic genetic hearing loss · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.01) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
28 unique Pathogenic / Likely Pathogenic· 115 VUS of 274 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.93LOEUF
pLI 0.009
Z-score 1.73
OE 0.44 (0.230.93)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.18Z-score
OE missense 0.96 (0.851.09)
173 obs / 179.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.44 (0.230.93)
00.351.4
Missense OE?0.96 (0.851.09)
00.61.4
Synonymous OE?1.01
01.21.6
LoF obs/exp: 5 / 11.3Missense obs/exp: 173 / 179.7Syn Z: -0.08

This gene — mechanism propensity

DN
0.6841th %ile
GOF
0.6540th %ile
LOF
0.3356th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

274 submitted variants in ClinVar

Classification Summary

Pathogenic14
Likely Pathogenic14
VUS115
Likely Benign92
Benign19
Conflicting16
14
Pathogenic
14
Likely Pathogenic
115
VUS
92
Likely Benign
19
Benign
16
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
8
5
1
0
14
Likely Pathogenic
10
4
0
0
14
VUS
3
103
7
2
115
Likely Benign
1
8
36
47
92
Benign
0
0
18
1
19
Conflicting
16
Total221206250270

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

19 pathogenic / likely-pathogenic (of 27) ClinVar copy-number / structural variants overlap GIPC3 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

GIPC3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →